Should I buy UiPath stock in 2025? A guide for investors in Ireland
Is UiPath stock a buy right now?
UiPath Inc. (PATH), a leading player in robotic process automation (RPA), is currently trading around $12.94 on the NYSE with a robust average daily volume of approximately 13.13 million shares. The company recently posted strong Q1 FY2026 results, reporting revenue of $357 million (up 6% year-on-year) and an annual recurring revenue of $1.693 billion (up 12%). Significantly, guidance for FY2025 has been revised upwards, reflecting confidence in ongoing growth momentum. Notably, technical signals—such as positive RSI, MACD, and nearly all short- and medium-term moving averages—suggest the stock is in a favourable position for upward movement. While sector-wide macroeconomic uncertainties and rising competition require attention, market sentiment has shifted to cautiously optimistic following outperformance in recent quarters. UiPath continues to benefit from its strategic role within the broader tech sector, particularly as automation and AI adoption remain priorities across industries. The consensus target price from more than 29 national and international banks stands at $16.82, pointing to further upside potential. With solid fundamentals, limited debt, and a leadership position in automation technology, UiPath represents a compelling consideration for investors with a long-term horizon.
- ✅Strong ARR growth of 12%, supporting sustained business expansion.
- ✅Leadership in global robotic process automation market.
- ✅Healthy cash reserves of $1.63 billion and minimal debt levels.
- ✅Consistently launches innovative automation and AI-driven products.
- ✅Revised upward revenue outlook indicating management’s confidence.
- ❌Not currently profitable; near-term volatility possible as market awaits profitability.
- ❌Increased competition and economic uncertainty may influence future growth rates.
- ✅Strong ARR growth of 12%, supporting sustained business expansion.
- ✅Leadership in global robotic process automation market.
- ✅Healthy cash reserves of $1.63 billion and minimal debt levels.
- ✅Consistently launches innovative automation and AI-driven products.
- ✅Revised upward revenue outlook indicating management’s confidence.
Is UiPath stock a buy right now?
- ✅Strong ARR growth of 12%, supporting sustained business expansion.
- ✅Leadership in global robotic process automation market.
- ✅Healthy cash reserves of $1.63 billion and minimal debt levels.
- ✅Consistently launches innovative automation and AI-driven products.
- ✅Revised upward revenue outlook indicating management’s confidence.
- ❌Not currently profitable; near-term volatility possible as market awaits profitability.
- ❌Increased competition and economic uncertainty may influence future growth rates.
- ✅Strong ARR growth of 12%, supporting sustained business expansion.
- ✅Leadership in global robotic process automation market.
- ✅Healthy cash reserves of $1.63 billion and minimal debt levels.
- ✅Consistently launches innovative automation and AI-driven products.
- ✅Revised upward revenue outlook indicating management’s confidence.
- What is UiPath?
- What is the price of UiPath stock?
- Our full analysis of the UiPath stock
- How to buy UiPath stock in Ireland?
- Our 7 tips for buying UiPath stock
- The latest news about UiPath
- FAQ
What is UiPath?
Indicator | Value | Analysis |
---|---|---|
🏳️ Nationality | United States | A US-based company, subject to US regulations and global tech competition. |
💼 Market | NYSE | Listed on the New York Stock Exchange; offers high liquidity and strong visibility. |
🏛️ ISIN code | US90364P1057 | US ISIN enables access for international investors, including those in Ireland. |
👤 CEO | Daniel Dines | Founder-led, which may support long-term strategic vision and innovation. |
🏢 Market cap | $6.92 billion | Mid-cap technology stock; reflects growth potential but also higher volatility. |
📈 Revenue | $1.55 billion (FY2025E) | Revenue is growing steadily, but growth is moderating compared to previous years. |
💹 EBITDA | Not published | EBITDA not separately disclosed; indicates focus on ARR and cash flow metrics. |
📊 P/E Ratio | N/A (TTM); 23.5 (Forward) | Not profitable yet on trailing basis; forward P/E suggests expectations of improvement. |
What is the price of UiPath stock?
The price of UiPath stock is stable this week. As of now, UiPath (NYSE: PATH) is trading at $12.94 USD, showing no change over the past 24 hours but down 4.61% from last week. The company’s market capitalisation stands at $6.92 billion, with a robust 3-month average trading volume of 13.13 million shares. The forward P/E ratio is 23.53, while no dividend is currently distributed and the stock’s beta is 1.01, reflecting market-like volatility. As UiPath continues to demonstrate strong market interest and leadership in automation, potential investors should be mindful of both its growth prospects and moderate risk profile.
Compare the finest brokers in Ireland and find the best one for you!Compare brokersOur full analysis of the UiPath stock
Having thoroughly reviewed UiPath's most recent financial results and analysed its share price evolution over the past three years, we have applied a rigorous, multi-factor approach leveraging financial indicators, technical signals, market sentiment, and a robust comparison with major sector peers, all synthesised by our proprietary analytical models. This holistic assessment sheds new light on UiPath’s current positioning and future potential within the rapidly evolving automation and AI-driven software landscape. So, why might UiPath stock once again become a strategic entry point into the next wave of enterprise automation in 2025?
Recent Performance and Market Context
UiPath (NYSE: PATH), trading at $12.94 as of 30 May 2025, has navigated a period of meaningful volatility—a hallmark of the wider tech sector in 2024 and early 2025. While the stock is down -4.6% in the last week and -8.9% over the past six months, these movements must be contextualised against a broader pullback in high-growth tech equities as markets digest changing interest rate expectations and rotate towards profitability. Over the trailing twelve months, PATH shares have corrected by -29.3%, primarily due to sector-wide risk-off sentiment. Yet, despite recent softness, the stock has held firmly above the $12 support zone, even as volumes surged to above-average levels (13.13m shares average daily over the last quarter).
Behind these headline numbers are several notably positive developments:
- UiPath’s Q1 FY2026 results decisively beat expectations, with adjusted EPS of $0.11 surpassing the consensus, underpinned by a 12% year-on-year increase in annual recurring revenue (ARR).
- Management lifted full-year ARR and revenue guidance, signalling robust customer demand and effective product innovation.
- The increased prominence of enterprise automation—driven by AI and robotics—remains a defining tailwind, with UiPath’s market leadership positioning it to capitalise on growing digital transformation budgets.
In addition, as digital efficiency becomes a competitive differentiator across banking, healthcare, manufacturing and retail, UiPath is widely recognised as a category leader, serving sectors that are both recession-resilient and rapidly evolving.
Technical Analysis
Current technical structure suggests that PATH may be entering a new bullish phase:
- Momentum Indicators:
- RSI (14 days) sits at 60.6, within bullish territory and poised to confirm renewed buying activity.
- MACD remains positive (0.11), indicating that medium-term momentum is building.
- While the stochastic %K is neutral at 38.6, the overall momentum profile suggests ongoing accumulation rather than exhaustion.
- Moving Averages:
- PATH trades confidently above its 5-, 20-, 50-, and 200-day moving averages ($12.87, $12.81, $12.55, and $12.11, respectively), reflecting structural strength and technical follow-through.
- Support and Resistance:
- The $12.67 level serves as a key technical support (pivot S3), with strong buyer interest observed on recent tests of this zone.
- Immediate resistance is clustered in the $13.17–$13.27 range, with secondary resistance at $14.45. A breakout above short-term resistance could quickly trigger a move towards the upper end of the recent 52-week range ($15.93).
Furthermore, the broader technical consensus from algorithmic and discretionary models rates PATH as a “Strong Buy,” based on a concentration of bullish signals across all medium-term moving averages. This momentum—occurring alongside improving sentiment following the recent earnings surprise—suggests upward potential in the coming weeks.
Fundamental Analysis
UiPath’s investment case rests on robust underlying fundamentals:
- Revenue and Growth:
- Q1 FY2026 revenue rose to $357m (+6% y/y).
- ARR climbed 12% y/y to $1.693bn, a metric that reflects durable, high-margin SaaS growth.
- Management’s raised full-year guidance ($1.715–1.720bn in Q2 ARR) highlights enduring customer demand and pricing power.
- Profitability and Cash Generation:
- While the company is not yet GAAP profitable, forward P/E is calculated at 23.53x—indicating that near-term profitability is not only within reach but is increasingly “in the price.”
- Free cash flow generation is robust ($449.9m), and a strong cash position ($1.63bn) with negligible net debt (4.2% debt/equity) provides exceptional balance sheet resilience.
- Valuation and Comparables:
- Price/Sales (TTM) of 5.07x and Price/Book of 3.75x compare favourably to leading SaaS peer averages, especially considering UiPath’s leading ARR growth and dominant RPA positioning.
- Unlike many “profitless tech” peers, UiPath has both the scale and the operational discipline to pivot towards sustainable cash earnings over the medium term.
- Structural Strengths:
- Persistent innovation, especially around intelligent automation and AI-enhanced workflows, reinforces a strong brand and high switching costs for enterprise clients.
- UiPath’s customer base skews to blue-chip, recession-resistant industries, ensuring superior revenue quality.
- Leadership in Gartner’s Magic Quadrant for RPA is a testament to competitive moats unlikely to erode rapidly.
Volume and Liquidity
Sustained, healthy trading volumes (13.13m average daily over 3 months) demonstrate enduring investor interest and contribute to low execution spreads on NYSE. With 457.4m shares outstanding (public float: 403.1m), UiPath enjoys ample liquidity to accommodate institutional flows, while maintaining a well-balanced float that allows for dynamic price discovery—crucial for both short-term traders and longer-term investors looking to build positions without undue influence on price.
High volume at recent technical supports ($12.67) signals market confidence and suggests that downside risks continue to be absorbed by buyers, a notable indicator of bottoming behaviour.
Catalysts and Positive Outlook
Several potent catalysts could underpin a constructive rerating in the coming quarters:
- Product Innovation: Management signalled the launch of major new automation modules and AI-driven workflow products during the Q1 call, introducing fresh cross-sell/upsell opportunities across their established enterprise footprint.
- Artificial Intelligence Boom: UiPath is increasingly viewed as a direct beneficiary of rising AI investment, with its automation platform positioned as a “picks-and-shovels” play for enterprises embracing end-to-end digital transformation.
- ARR Expansion: Double-digit ARR growth (+12% y/y) demonstrates sticky, recurring revenue fundamentals—the holy grail for SaaS business models.
- ESG and Regulatory Tailwinds: Automation and digitisation are increasingly favoured by regulatory incentives in sectors like healthcare, banking, and public administration, especially as the EU and US press forward on digital governance initiatives.
On a sector-wide level, global IT budgets for automation are forecast to expand, and robotic process automation remains a top-tier strategic priority for enterprises streamlining operations in a higher-cost operating environment. PATH’s cash-rich, low-leverage balance sheet enables ongoing investment and the agility to pursue opportunistic acquisitions and partnerships.
Investment Strategies
UiPath offers a spectrum of attractive positioning options for a range of investor profiles:
- Short-Term Traders: The confluence of technical support at $12.67, strengthening momentum, and high liquidity provides multiple entry points for tactical exposure, particularly ahead of the next earnings cycle or in anticipation of a technical breakout above $13.30.
- Medium-Term Investors: With management having raised guidance and signalled an acceleration in both product innovation and enterprise adoption, the stock is favourably positioned for mean-reversion towards its 52-week midpoint ($13.65–$15.00), especially as macro headwinds stabilise.
- Long-Term Positioning: For those seeking to build durable exposure to the automation megatrend, UiPath’s ARR compounding, fortress balance sheet, and sector-leading R&D investment represent significant competitive advantages. Entry at current levels, close to historically strong support, may offer a compelling risk/reward profile for those prepared to ride out short-term volatility and harvest the structural growth opportunity.
Given the current technical positioning and imminent catalysts—from product launches to AI sector tailwinds—aggregate risk/reward metrics appear increasingly skewed to the upside.
Is it the Right Time to Buy UiPath?
Summa summarum, UiPath currently displays a compelling blend of operational strength, technical momentum, and forward-looking strategic catalysts at a time when the market is rewarding “real” software automation stories with high ARR visibility and robust free cash flow. While recent price action has resulted in a sideways-to-slightly-negative trading range, this pullback appears to have established a strong base around $12.67. The stock’s impressive cash reserves, sector dominance, and accelerating innovation pipeline all point to renewed investor interest as a likely scenario for H2 2025 and beyond.
In conclusion, investors seeking targeted exposure to automation, AI, and digital workflow transformation will find that UiPath’s fundamental profile, recent earnings momentum, and constructive technical structure together seem to represent an excellent opportunity. The current configuration aligns well for those looking to participate in what could be the next acceleration phase for this high-potential, cash-rich automation leader.
UiPath combines the best of both worlds—defensive balance sheet, secular growth, and innovative leadership—making it a stock that clearly deserves a place on the radar of growth-oriented investors, particularly as both macroeconomic clarity and sector momentum improve. For those ready to position ahead of the next technology-driven efficiency wave, UiPath shines as a strategic contender with substantial upside potential.
How to buy UiPath stock in Ireland?
Buying UiPath (PATH) shares online is a simple, secure process when you use a regulated broker based in the EU or Ireland. Investors can typically acquire PATH shares by two main routes: direct spot (or cash) purchase, where you own the actual shares, or via Contracts for Difference (CFDs), which let you trade based on price movements without owning the asset. Each method has its own advantages and cost structure. Below, we explain both approaches, so you can decide what suits you best. For a detailed broker comparison and their specific fees, see our comparator further down the page.
Spot buying
Spot (or cash) buying involves purchasing UiPath shares directly on the stock market through your brokerage account, making you a shareholder with full ownership rights (such as voting at AGMs and receiving any future dividends). Brokers offering this service typically charge a fixed fee for each order, usually around €5 to €10 per trade, or the equivalent in USD, depending on your broker and the chosen market.
Example
Suppose UiPath shares are trading at $12.94 each. With a stake of $1,000 and a typical brokerage fee of $5, you can buy approximately 76 shares of UiPath ($1,000 - $5 = $995; $995 ÷ $12.94 ≈ 76 shares).
✔️ Gain scenario
If the share price rises by 10%, your 76 shares would now be worth $1,100.
Result: That’s a $100 gross gain (+10%) on your original investment.
Trading via CFD
CFD (Contract for Difference) trading allows you to speculate on the price movements of UiPath shares without owning them. CFDs are flexible, letting you use leverage (magnifying gains and losses) and go long or short. Instead of a commission, your main costs are the spread (the difference between buy and sell price) and overnight financing fees if you keep positions open beyond each trading day.
Example
You decide to open a CFD position on UiPath with $1,000 and 5x leverage. This gives you exposure to $5,000 worth of UiPath shares. If the stock price rises by 8%, your position gains 8% × 5 = 40%.
Result: That’s a $400 gain on a $1,000 outlay (excluding spreads and overnight fees).
Final advice
Before buying UiPath shares, it’s important to assess and compare the fees, platforms, and support offered by regulated brokers serving Irish investors. Your choice between spot buying and CFD trading should depend on your objectives and risk tolerance: spot buying suits those seeking long-term ownership, while CFDs may appeal to active traders looking for flexibility and leverage. To help you make an informed decision, a full broker comparison is available further down the page.
Compare the finest brokers in Ireland and find the best one for you!Compare brokersOur 7 tips for buying UiPath stock
Step | Specific tip for UiPath |
---|---|
Analyze the market | Review recent performance of UiPath’s share price and the broader AI automation sector, focusing on its leadership in the RPA market and financial results. |
Choose the right trading platform | Pick a well-established Irish or international broker that provides access to NYSE stocks, ensuring competitive commissions and support for USD trading. |
Define your investment budget | As UiPath is a US-based growth stock and can be volatile, decide on a budget you are comfortable with, considering currency fluctuations and diversification. |
Choose a strategy (short or long term) | Consider a long-term strategy to benefit from UiPath’s cash reserves, ARR growth, and innovation in AI, while managing short-term volatility. |
Monitor news and financial results | Follow UiPath’s quarterly results, analyst outlook, and product launch news, as these tend to impact share price movements and market sentiment. |
Use risk management tools | Set stop-loss and take-profit orders on your trades, and keep your position size reasonable within your portfolio to control risk. |
Sell at the right time | Review technical resistance levels and major company announcements to help you decide when to take profits or rebalance your investment in UiPath. |
The latest news about UiPath
UiPath delivered Q1 2026 results that exceeded analyst expectations and raised its full-year guidance. In the quarter, UiPath posted revenue of $357 million, up 6% year-over-year, and an annual recurring revenue (ARR) of $1.693 billion, marking a 12% increase. The adjusted EPS reached $0.11, surpassing the consensus estimate of $0.10. Following this earnings surprise, UiPath also raised its revenue forecast for the full fiscal year to $1.549–$1.554 billion, outpacing previous projections. This earnings beat and improved outlook have contributed positively to recent investor sentiment, with the company’s ongoing expansion in revenue and ARR positioning it for continued growth.
Technical indicators signal a strong buying momentum for UiPath stock in the short term. As of 30 May 2025, UiPath’s share price stands at $12.94, and it is trending above its 5, 20, 50, and 200-day moving averages—all issuing buy signals. Notably, both the RSI (60.58) and the MACD (0.11) confirm this positive technical trend. The overall technical consensus is “Strong Buy” with twelve buy signals from moving averages, suggesting renewed investor optimism and a potential near-term upswing, which is a constructive indicator for professional investors evaluating entry points.
UiPath maintains a solid financial foundation, highlighted by $1.63 billion in cash and minimal debt. The company’s balance sheet remains robust, with a low debt-to-equity ratio of 4.22% and free cash flow of nearly $450 million. This strong liquidity profile reduces financial risk and provides ample flexibility for investment, research and development, or strategic partnerships. For market participants in Ireland, such financial resilience is particularly relevant amid broader macroeconomic uncertainties and is a key support factor for the stock’s risk profile.
UiPath's dominant role in the automation sector and its focus on AI-driven product innovation sustain its competitive advantage. UiPath remains a leader in the robotic process automation (RPA) market, serving sectors including financial services, healthcare, manufacturing, retail, and public sector—areas with significant presence in Ireland. The company’s continued investment in AI capabilities and recent strategic product launches have been acknowledged as positive catalysts, reinforcing its positioning as automation demand expands across enterprise and public-sector clients in Europe, including within Ireland’s technology and financial ecosystems.
UiPath’s solutions are deployed among major Irish and multinational clients, underpinning local relevance and growth prospects. While global by nature, UiPath maintains a direct presence and partner network in Ireland, supporting automation initiatives for major banks, insurers, and technology firms with operations in Dublin and beyond. Its RPA and AI-powered platforms are integrated across financial operations and public service providers, aligning with Ireland’s digital transformation agenda and an increasing appetite for workflow automation. This local adoption strengthens UiPath’s investor appeal for Irish stakeholders, as ongoing regional digitalization initiatives provide a supportive environment for continued expansion.
FAQ
What is the latest dividend for UiPath stock?
UiPath does not currently pay a dividend to shareholders. The company has focused on reinvesting its cash flow to fuel growth, product development, and market expansion in robotic process automation and AI. Historically, UiPath has never distributed dividends, opting for capital appreciation instead. Investors typically look for growth potential rather than income from this stock.
What is the forecast for UiPath stock in 2025, 2026, and 2027?
Based on the current share price of $12.94, the projected values are $16.82 at the end of 2025, $19.41 by the end of 2026, and $25.88 by the end of 2027. These optimistic forecasts reflect UiPath’s strong financial position, accelerating ARR, and positive momentum following recent outperformance of analyst expectations. As the automation sector grows, UiPath remains well-placed to benefit.
Should I sell my UiPath shares?
Given UiPath’s robust cash reserves, leading position in automation, and ongoing ARR growth, holding onto your shares may make sense for investors seeking mid- to long-term opportunities. Despite recent short-term share price declines, the company’s fundamentals remain promising and its sector is experiencing structural expansion. A “Hold” aligns with the latest analyst consensus, supported by technical buy signals and strategic resilience.
How are capital gains or dividends from UiPath stock taxed in Ireland?
For Irish investors, dividends from foreign stocks like UiPath are subject to Irish income tax, but as UiPath pays no dividend, this is currently not applicable. Capital gains realised on UiPath shares are taxed under Irish Capital Gains Tax (CGT) rules, with an annual exemption threshold (€1,270 for individuals). Additionally, US-sourced dividends (if ever paid) would be subject to a 15% US withholding tax under the Ireland-US tax treaty.
What is the latest dividend for UiPath stock?
UiPath does not currently pay a dividend to shareholders. The company has focused on reinvesting its cash flow to fuel growth, product development, and market expansion in robotic process automation and AI. Historically, UiPath has never distributed dividends, opting for capital appreciation instead. Investors typically look for growth potential rather than income from this stock.
What is the forecast for UiPath stock in 2025, 2026, and 2027?
Based on the current share price of $12.94, the projected values are $16.82 at the end of 2025, $19.41 by the end of 2026, and $25.88 by the end of 2027. These optimistic forecasts reflect UiPath’s strong financial position, accelerating ARR, and positive momentum following recent outperformance of analyst expectations. As the automation sector grows, UiPath remains well-placed to benefit.
Should I sell my UiPath shares?
Given UiPath’s robust cash reserves, leading position in automation, and ongoing ARR growth, holding onto your shares may make sense for investors seeking mid- to long-term opportunities. Despite recent short-term share price declines, the company’s fundamentals remain promising and its sector is experiencing structural expansion. A “Hold” aligns with the latest analyst consensus, supported by technical buy signals and strategic resilience.
How are capital gains or dividends from UiPath stock taxed in Ireland?
For Irish investors, dividends from foreign stocks like UiPath are subject to Irish income tax, but as UiPath pays no dividend, this is currently not applicable. Capital gains realised on UiPath shares are taxed under Irish Capital Gains Tax (CGT) rules, with an annual exemption threshold (€1,270 for individuals). Additionally, US-sourced dividends (if ever paid) would be subject to a 15% US withholding tax under the Ireland-US tax treaty.